Navigating the cutting-edge confluence of 3D printing and cellular biology, Inventia Life Science emerges as a trailblazer, pioneering a transformative revolution. Their mission is profound yet clear: to customise human cells for more effective cancer drug testing. At the heart of this endeavour lies their state-of-the-art platform, which leverages the versatility of both natural and synthetic hydrogel bioinks. The power to bioprint human cells is not just a technological feat; it’s a game-changer, offering unprecedented avenues in cancer research and treatment optimization.